Endo International Ordinary Shares reported $223.36M in Pre-Tax Profit for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US $ 6567M 197M
Amarin AMRN:US $ -28.35M 44.74M
Bristol Myers Squibb BMY:US $ 5386M 595M
Coherus Biosciences CHRS:US $ -96.08M 50.36M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
JAZZ PHA JAZZ:US $ 321.29M 19.04M
Merk MRK:US $ 6309M 1525M
Novartis NOVN:VX SF 3912M 230M
Pacira Pharmaceuticals PCRX:US $ 39.79M 19.7M
Revance Therapeutics RVNC:US $ -64.34M 1.24M
Supernus Pharmaceuticals SUPN:US $ 14.72M 12.67M
Takeda 4502:JP Y -54047M 126240M
Teva Pharmaceutical TEVA:IT -971000000 796M
Xeris Pharmaceuticals Inc XERS:US $ -34122000 16.67M
Zoetis ZTS:US $ 769M 188M